Inflectra Uses Side Effects Dosages Precautions
A biosimilar drug is “highly similar” to a biologic drug. Inflectra, like Remicade, blocks the action of an immune-system cell called tumor necrosis factor (TNF). This class of drugs is called TNF antagonists, anti-TNF drugs, or TNF blockers. Inflectra was the first Remicade biosimilar to be approved. The FDA has since approved several others: Renflexis (infliximab-abda), Ixifi (infliximab-qbtx), and Avsola (infliximab-axxq). (To distinguish between the different products, these have been given a new brand name,in addition to a suffix containing four consonants to the end of each generic name....